- Home
- ACR vs OBIO Comparison
ACR vs OBIO Comparison
Compare ACR & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- OBIO
- Stock Information
- Founded
- ACR 2005
- OBIO 2017
- Country
- ACR United States
- OBIO United States
- Employees
- ACR N/A
- OBIO N/A
- Industry
- ACR Real Estate Investment Trusts
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- ACR Real Estate
- OBIO Health Care
- Exchange
- ACR Nasdaq
- OBIO Nasdaq
- Market Cap
- ACR 139.0M
- OBIO 124.9M
- IPO Year
- ACR N/A
- OBIO N/A
- Fundamental
- Price
- ACR $17.30
- OBIO $3.01
- Analyst Decision
- ACR Buy
- OBIO Strong Buy
- Analyst Count
- ACR 2
- OBIO 5
- Target Price
- ACR $17.50
- OBIO $14.20
- AVG Volume (30 Days)
- ACR 36.0K
- OBIO 236.8K
- Earning Date
- ACR 07-30-2025
- OBIO 08-11-2025
- Dividend Yield
- ACR N/A
- OBIO N/A
- EPS Growth
- ACR N/A
- OBIO N/A
- EPS
- ACR 0.34
- OBIO N/A
- Revenue
- ACR $83,545,000.00
- OBIO $2,886,000.00
- Revenue This Year
- ACR $3.57
- OBIO $20.47
- Revenue Next Year
- ACR N/A
- OBIO $11.45
- P/E Ratio
- ACR $52.00
- OBIO N/A
- Revenue Growth
- ACR 6.92
- OBIO 30.23
- 52 Week Low
- ACR $12.70
- OBIO $2.37
- 52 Week High
- ACR $23.81
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- ACR 34.98
- OBIO 47.82
- Support Level
- ACR $17.64
- OBIO $2.91
- Resistance Level
- ACR $18.06
- OBIO $3.48
- Average True Range (ATR)
- ACR 0.56
- OBIO 0.26
- MACD
- ACR -0.07
- OBIO -0.01
- Stochastic Oscillator
- ACR 0.26
- OBIO 28.78
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.